NCT03080740View on ClinicalTrials.gov

The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis

PHASE4UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

December 31, 2017

Conditions
Bacterial Vaginosis
Interventions
DRUG

Clindamycin palmitate hydrochloride dispersible tablet

300mg, oral after meal, twice daily, a total of 7days

DRUG

Metronidazole Tablet

400mg, oral after meal , twice daily, a total of 7days

Trial Locations (1)

100034

RECRUITING

Peking University first hospital, Beijing

Sponsors
All Listed Sponsors
lead

Guangzhou Yipinhong Pharmaceutical CO.,LTD

INDUSTRY

NCT03080740 - The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis | Biotech Hunter | Biotech Hunter